• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Genpact Limited filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    5/7/25 4:07:53 PM ET
    $G
    Professional Services
    Consumer Discretionary
    Get the next $G alert in real time by email
    g-20250507
    0001398659FALSE00013986592025-05-072025-05-07

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM 8-K

    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the
    Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): May 7, 2025
    GENPACT LIMITED
    (Exact name of registrant as specified in its charter)
    Bermuda     001-3362698-0533350
    (State or other jurisdiction
    of incorporation)
       (Commission
         File Number)
    (I.R.S. Employer
    Identification No.)
    Canon's Court, 22 Victoria Street
    Hamilton HM 12, Bermuda
    (Address of Principal Executive Offices) (Zip Code)
    Registrant's telephone number, including area code: (441) 298-3300
    Not Applicable
    (Former name or former address, if changed since last report)
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
    Securities registered pursuant to Section 12(b) of the Act:
     
    Title of each classTrading SymbolName of each exchange on which registered
    Common shares, par value $0.01 per shareGNew York Stock Exchange
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



    Item 2.02Results of Operations and Financial Condition.
    On May 7, 2025, Genpact Limited (the “Company”) issued a press release announcing its financial results for the three months ended March 31, 2025.  The Company is furnishing this Form 8-K pursuant to Item 2.02, “Results of Operations and Financial Condition.” A copy of the press release, attached hereto as Exhibit 99.1, is incorporated herein by reference.
    The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
    The Company is making reference to non-GAAP financial information in the press release and on the conference call.  A reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures is contained in the attached press release.

    Item 9.01.Financial Statements and Exhibits.
    (d)Exhibits:
     
    Exhibit 99.1  
    Press release dated May 7, 2025
    Exhibit 104 
    Cover Page Interactive Data File (embedded within the Inline XBRL document)



    Signature
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
      GENPACT LIMITED
         
    Date: May 7, 2025 By: /s/ Heather D. White
      Name: Heather D. White
      Title: Senior Vice President, Chief Legal Officer and Secretary

    Get the next $G alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $G

    DatePrice TargetRatingAnalyst
    2/7/2025$45.00 → $60.00Hold → Buy
    TD Cowen
    1/21/2025$44.00 → $55.00Hold → Buy
    Jefferies
    7/17/2024$43.00 → $40.00Underweight → Neutral
    JP Morgan
    1/30/2024$40.00Neutral
    Mizuho
    12/15/2023$38.00Outperform → Neutral
    Robert W. Baird
    8/22/2023$40.00Neutral → Underweight
    JP Morgan
    7/18/2023$46.00 → $42.00Buy → Neutral
    Citigroup
    12/15/2022$55.00 → $50.00Overweight → Neutral
    JP Morgan
    More analyst ratings

    $G
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Gangestad Nicholas C bought $87,940 worth of shares (2,000 units at $43.97) (SEC Form 4)

      4 - Genpact LTD (0001398659) (Issuer)

      5/14/25 4:19:22 PM ET
      $G
      Professional Services
      Consumer Discretionary